COMMON STOCK | 6. COMMON STOCK a) Stock Options The Company has a rolling stock option plan (the “Plan”) whereby the Company may grant stock options to executive officers and directors, employees, and consultants at an exercise price to be determined by the board of directors, provided the exercise price is not lower than the greater of (i) the last closing price of the Company’s common shares on the TSX and (ii) the volume weighted average closing price of the Company’s common shares on the TSX for the five days immediately prior to the date of grant. The Plan provides for the issuance of up to 10% of the Company’s issued Common Shares as at the date of grant with each stock option having a maximum term of ten years. The board of directors has the exclusive power over the granting of options and their vesting provisions. Stock option transactions are summarized as follows: Number of Weighted Balance, June 30, 2016 11,465,000 $ 0.69 Granted 710,000 0.96 Exercised - - Cancelled/expired (150,000 ) 0.62 Balance, December 31, 2016 12,025,000 $ 0.71 The following table summarizes the information and assumptions used to determine option costs for the six-month period ended December 31, 2016: Fair value per option granted during the period (C$) $ 0.50 Risk-free interest rate 0.75 % Expected dividend yield 0 % Expected stock price volatility (historical basis) 97.2 % Expected option life in years 2.15 The following table summarizes information about stock options outstanding at December 31, 2016: Exercise Expiry date Number Aggregate Number Aggregate $ 0.50 May 9, 2017 370,000 $ 93 370,000 $ 93 $ 0.62 January 19, 2021 5,425,000 705 2,712,500 353 $ 0.65 May 20, 2017 50,000 5 50,000 5 $ 0.65 July 28, 2017 1,250,000 125 1,250,000 125 $ 0.76 September 2, 2017 500,000 - 500,000 - $ 0.80 December 22, 2017 3,220,000 - 3,220,000 - $ 0.94 April 28, 2018 500,000 - 500,000 - $ 0.96 July 21, 2021 710,000 - - - Balance December 31, 2016 12,025,000 $ 928 8,602,500 $ 576 The aggregate intrinsic value in the preceding table represents the total intrinsic value, based on the Company’s closing stock price of C$0.75 as of December 31, 2016, which would have been received by the option holders had all option holders exercised their options as of that date. In-the-money options vested and exercisable as of December 31, 2016, totaled 4,382,500. As of December 31, 2016, there was $160 of unrecognized compensation cost related to unvested share-based compensation arrangements granted under the Plan. The cost is expected to be recognized over a remaining weighted average period of approximately 1.0 years. b) Warrants Warrant transactions are summarized as follows: Warrants Weighted average Balance June 30, 2016 22,733,685 $ 0.74 Granted - - Exercised (3,447,137 ) 0.65 Expired (4,114,353 ) 0.65 Balance, December 31, 2016 15,172,195 $ 0.79 At December 31, 2016, the Company has outstanding exercisable warrants, as follows: Number Exercise Expiry Date 182,910 $ 0.85 February 27, 2017 2,714,000 1.00 February 27, 2017 3,125,000 0.72 December 22, 2018 9,150,285 0.75 January 19, 2019 15,172,195 |